 TFF Pharmaceuticals, Inc. NASDAQ:TFFP Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO Director Dale Christensen - Head, Clinical Development Kirk Coleman - CFO, Treasurer Secretary Robert Williams - Technology Inventor Special Advisor Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Vernon Bernardino - H.C. Wainwright Co. Michael Okunewitch - Maxim Group Operator Greetings, and welcome to the TFF Pharmaceuticals, Inc. Third Quarter 2022 Earnings Conference Call. 